Evidence map›Paper›PMID 30811011›Full record

ReviewHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2019

The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease.

Angela Albarosa Rivellese, Paola Ciciola, Giuseppina Costabile, Claudia Vetrani, Marilena Vitale

Abstract readReview
PubMed Publisher
In one paragraph

Review in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. The Effects of a New Generation of Nutraceutical Compounds on Lipid Profile and Glycaemia in Subjects with Pre-hypertension.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2019
    Trial
  4. Review
  5. Review
  6. Nutraceuticals in Chronic Coronary Syndromes: Preclinical Data and Translational Experiences.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. Commentary to "The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease".High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Angela Albarosa RivelleseDepartment of Clinical Medicine and Surgery, "Federico II" University of Naples, Via S. Pansini, 5, Naples, Italy.
Paola CiciolaDepartment of Clinical Medicine and Surgery, "Federico II" University of Naples, Via S. Pansini, 5, Naples, Italy.
Giuseppina CostabileDepartment of Clinical Medicine and Surgery, "Federico II" University of Naples, Via S. Pansini, 5, Naples, Italy. giuseppina.costabile@unina.it.ORCID http://orcid.org/0000-0001-5761-8002
Claudia VetraniDepartment of Clinical Medicine and Surgery, "Federico II" University of Naples, Via S. Pansini, 5, Naples, Italy.
Marilena VitaleDepartment of Clinical Medicine and Surgery, "Federico II" University of Naples, Via S. Pansini, 5, Naples, Italy.
University of Naples Federico II · ITFederico II University Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases (CVDs) are the main causes of mortality and disability worldwide. Although the initial therapeutic approach to improve the main cardiovascular (CV) risk factors is based on nonpharmacological measures, mainly lifestyle modifications, compliance to recommendations is often poor and inadequate. Therefore, in recent years the use of several nutraceuticals, i.e., nutrients and/or bioactive compounds of plant or microbial origin with potentially healthful effects, has become widespread. However, to date, the scientific data on the possible benefits of the use of nutraceuticals are still inconclusive, due to the absence of adequately controlled intervention studies at least for some of them. Against this background, the scientific evidence derived from controlled intervention studies in relation to the effects of some nutraceuticals (i.e. fiber, phytosterols, soy products, red yeast rice, polyphenols and berberine) on the main CV risk factors (body weight, blood pressure, blood glucose levels and plasma lipids) in humans will be reviewed.

Indexed as

Dietary SupplementsAntihypertensive AgentsAnti-Obesity AgentsBiomarkersBlood GlucoseBlood PressureBody WeightCardiovascular DiseasesHealth StatusHumansHypoglycemic AgentsHypolipidemic AgentsLipidsProtective FactorsRisk FactorsTreatment OutcomeAntihypertensive AgentsAnti-Obesity AgentsBiomarkersBlood GlucoseHypoglycemic AgentsHypolipidemic AgentsLipidsBlood glucoseBlood pressureBody weightNutraceuticalsPlasma lipids

Identifiers

PMID30811011
OpenAlexW2917106124

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.